RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction.
The Mixed Lineage Leukemia (MLL) protein is an important epigenetic regulator required for the maintenance of gene activation during development. MLL chromosomal translocations produce novel fusion proteins that cause aggressive leukemias in humans. Individual MLL fusion proteins have distinct leuke...
Huvudupphovsmän: | Wilkinson, A, Ballabio, E, Geng, H, North, P, Tapia, M, Kerry, J, Biswas, D, Roeder, R, Allis, C, Melnick, A, de Bruijn, M, Milne, T |
---|---|
Materialtyp: | Journal article |
Språk: | English |
Publicerad: |
2013
|
Liknande verk
Liknande verk
-
RUNX1 Is a Key Target in t(4;11) Leukemias that Contributes to Gene Activation through an AF4-MLL Complex Interaction
av: Wilkinson, A, et al.
Publicerad: (2013) -
PAF1 and FACT cooperate with MLL-AF4 to drive enhancer activity in leukemia
av: Milne, T, et al.
Publicerad: (2022) -
MLL-AF4 cooperates with PAF1 and FACT to drive high-density enhancer interactions in leukemia
av: Crump, NT, et al.
Publicerad: (2023) -
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia.
av: Kerry, J, et al.
Publicerad: (2017) -
MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation.
av: Godfrey, L, et al.
Publicerad: (2016)